Postmastectomy Radiation Therapy: Indications and Controversies

Surgical Clinics of North America

Volumn 87, Issue 2, 2007, Pages 511-526

  Lee, Marie Catherine ^a   Jagsi, Reshma ^a  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; TRASTUZUMAB;

AMBIGUITY; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL FEATURE; DECISION MAKING; HUMAN; LYMPH VESSEL; LYMPHEDEMA; MASTECTOMY; METASTASIS; MULTIPLE CYCLE TREATMENT; ONCOLOGY; OVERALL SURVIVAL; PATHOLOGY; PATIENT GUIDANCE; PRIORITY JOURNAL; PROGNOSIS; RADIATION PNEUMONIA; REVIEW; SURGEON; THORAX WALL DEFECT;

BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PRACTICE GUIDELINES; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE;

EID: 34248196396     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2007.01.011     Document Type: Review

References (45)

1. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366 9503 (2005) 2087-2106
2. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer: an overview of the randomised trials. N Engl J Med 333 (1995) 1444-1455
3. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 355 9217 (2000) 1757-1770
4. Cuzick J., et al. Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep 71 1 (1987) 15-29
5. Cuzick J., et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 12 3 (1994) 447-453
6. Whelan T.J., et al. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 18 6 (2000) 1220-1229
7. Van de Steene J., Soete G., and Storme G. Adjuvant radiotherapy for breast cancer significantly improves overall survival: the missing link. Radiother Oncol 55 3 (2000) 263-272
8. Recht A., and Edge S.B. Evidence-based indications for postmastectomy irradiation. Surg Clin North Am 83 4 (2003) 995-1013
9. Recht A., et al. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19 5 (2001) 1539-1569
10. Harris J.R., et al. Consensus statement on postmastectomy radiation therapy. Int J Radiat Oncol Biol Phys 1999 44 (1999) 5
11. Taylor M.E., et al. Postmastectomy radiotherapy. American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) (215 Suppl): p. 1153-70
12. Truong P.T., et al. Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy. CMAJ 170 8 (2004) 1263-1273
13. Ceilley E., et al. Radiotherapy for invasive breast cancer in North America and Europe: results of a survey. Int J Radiat Oncol Biol Phys 61 2 (2005) 365-373
14. Truong P.T., et al. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 61 5 (2005) 1337-1347
15. Recht A., et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol 17 6 (1999) 1689-1700
16. Taghian A., et al. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol 22 21 (2004) 4247-4254
17. Katz A., et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol 18 15 (2000) 2817-2827
18. Overgaard M., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337 14 (1997) 949-955
19. Overgaard M., et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353 9165 (1999) 1641-1648
20. Ragaz J., et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337 14 (1997) 956-962
21. Ragaz J., et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Nat Cancer Inst 97 2 (2005) 116-126
22. Pierce L.J. Treatment guidelines and techniques in delivery of postmastectomy radiotherapy in management of operable breast cancer. J Natl Cancer Inst Monogr 30 (2001) 117-124
23. Mignano JE, et al. Local recurrence after mastectomy in patient with T3N0 breast carcinoma treated without postoperative irradiation. Breast Cancer Res Treat 1996;41:255 (abstract).
24. Helinto M., et al. Post-mastectomy radiotherapy in pT3N0M breast cancer: is it needed?. Radiother Oncol 52 (1999) 213-217
25. Floyd S.R., et al. Low local recurrence rate without postmastectomy radiation in node-negative breast cancer patients with tumors 5 cm and larger. Int J Radiat Oncol Biol Phys 66 2 (2006) 358-364
26. Taghian AG, et al. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm.
27. Wallgren A., et al. Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII. J Clin Oncol 21 7 (2003) 1205-1213
28. Jagsi R., et al. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation. Int J Radiat Oncol Biol Phys 62 4 (2005) 1035-1039
29. Truong P.T., et al. Patient subsets with T1-T2, node-negative breast cancer at high locoregional recurrence risk after mastectomy. Int J Radiat Oncol Biol Phys 62 1 (2005) 175-182
30. Huang E.H., et al. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy. J Clin Oncol 22 23 (2004) 4691-4699
31. Huang E.H., et al. Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy. Int J Radiat Oncol Biol Phys 62 2 (2005) 351-357
32. Freedman G.M., et al. A close or positive margin after mastectomy is not an indication for chest wall irradiation except in women aged fifty or younger. Int J Radiat Oncol Biol Phys 41 3 (1998) 599-605
33. Truong P.T., et al. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer. Int J Radiat Oncol Biol Phys 58 3 (2004) 797-804
34. Hinrichs C.S., et al. Lymphedema secondary to postmastectomy radiation: incidence and risk factors. Ann Surg Oncol 11 6 (2004) 573-580
35. Pierce L.J. The use of radiotherapy after mastectomy: a review of the literature. J Clin Oncol 23 8 (2005) 1706-1717
36. Coen J.J., et al. Risk of lymphedema after regional nodal irradiation with breast conservation therapy. Int J Radiat Oncol Biol Phys 55 5 (2003) 1209-1215
37. Larson D., et al. Edema of the arm as a function of the extent of axillary surgery in patients with Stage I-II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys 12 (1986) 1575-1582
38. Paszat L.F., et al. Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, end-results cancer registries. J Clin Oncol 16 (1998) 2625-2631
39. Harris E.E., et al. Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment. J Clin Oncol 24 25 (2006) 4100-4106
40. Marks L.B., et al. The incidence and functional consequences of RT-associated cardiac perfusion defects. Int J Radiat Oncol Biol Phys (2005)
41. Amin-Zimmerman F., et al. Postmastectomy chest wall radiation with electron-beam therapy: outcomes and complications at the University of Louisville. Cancer J 11 3 (2005) 204-208
42. Taghian A., et al. Long-term risk of sarcoma following radiation treatment for breast cancer. Int J Radiat Oncol Biol Phys 21 2 (1991) 361-367
43. McArdle C.S., et al. Adjuvant radiotherapy and chemotherapy in breast cancer. Br J Surg 73 4 (1986) 264-266
44. Griem K.L., et al. The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy. J Clin Oncol 5 10 (1987) 1546-1555
45. Velez-Garcia E., et al. Postsurgical adjuvant chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes: a South-Eastern Cancer Study Group (SEG) Trial. Eur J Cancer 28A 11 (1992) 1833-1837